Furthermore, high expressions of FABP4, DDR2, and TNS1 were associated with worse overall survival in CRC patients (Supplementary Figures S1H–J), MYH11 and TNS1 were associated with advanced clinical stage (Supplementary Figures S1K,L). Here, FABP4 is linked to colorectal carcinoma.